SKIN vs MRVI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

SKIN

47.6
AI Score
VS
MRVI Wins

MRVI

55.0
AI Score

Investment Advisor Scores

SKIN

48score
Recommendation
HOLD

MRVI

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SKIN MRVI Winner
Revenue 64.91M 65.84M MRVI
Net Income -6.63M -3.73M MRVI
Gross Margin 68.5% 51.2% SKIN
Net Margin -10.2% -5.7% MRVI
Operating Income -1.80M -2.16M SKIN
ROE -12.0% -1.8% MRVI
ROA -1.4% -0.5% MRVI
Total Assets 473.23M 713.22M MRVI
Current Ratio 1.79 5.91 MRVI
Free Cash Flow -5.78M 4.23M MRVI

Relative Price Performance (Last 90 Days)

SKIN 1M: -4.5% · 3M: -19.5% MRVI 1M: +6.8% · 3M: +78.5%

Current Technical Phase

SKIN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 43.1 · Price: $0.69

MRVI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (22.4% over 20 days), RSI 54

RSI (14): 54.2 · Price: $6.57

Fundamentals Snapshot

Metric SKIN MRVI
Market Cap
Forward P/E 4.6 -71.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% 0.4%
Gross Margin 0.6% 0.3%
Operating Margin 0.0% 0.0%
EPS -0.12 -0.68
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MRVI is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.